Search Within

Igor Vivanco

  1. "2009"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (1)
Groups
  1. Epidemiology and Biostatistics (3)
  2. GSK Faculty (3)
  3. Human Oncology and Pathogenesis Program (3)
  4. Tow Center for Developmental Oncology (TCDO) (3)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  6. Biostatistics Service (2)

More Groups

People
  1. Ingo Mellinghoff (3)
  2. William Pao (3)
  3. Daniel Rohle (2)
  4. Fang Fang (2)
  5. Juliann Chmielecki (2)
  6. Lucia Regales (2)

More People

Years
  1. 2009 (4)
Publications
  1. Cancer Research (1)
  2. Cell Cycle (1)
  3. Journal of Clinical Investigation (1)
  4. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Association for Cancer Research (1)
  2. American Society for Clinical Investigation (1)
  3. National Academy of Sciences (1)
  4. Taylor & Francis Inc. (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EGFR T790M decreases growth potential of lung tumor cells with drug-sensitive EGFR mutant alleles in the absence of drug selection
    Meeting Abstract

    Chmielecki, J.; Foo, J.; Somwar, R.; Regales, L.; Vivanco, I.; Shen, R.; Michor, F.; Pao, W.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
    Journal Article

    Veeriah, S.; Brennan, C.; Meng, S.; Singh, B.; Fagin, J. A.; Solit, D. B.; Paty, P. B.; Rohle, D.; Vivanco, I.; Chmielecki, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer
    Journal Article

    Regales, L.; Gong, Y.; Shen, R.; de Stanchina, E.; Vivanco, I.; Goel, A.; Koutcher, J. A.; Spassova, M.; Ouerfelli, O.; Mellinghoff, I. K.; more...
    Journal of Clinical Investigation (2009)

    Fulltext@MSK | Save
  • 14-3-3σ and p21 synergize to determine DNA damage response following Chk2 inhibition
    Journal Article

    Meng, S.; Arbit, T.; Veeriah, S.; Mellinghoff, I. K.; Fang, F.; Vivanco, I.; Rohle, D.; Chan, T. A.
    Cell Cycle (2009)

    Fulltext@MSK | Save